16th
October 2018 - Global
Drug Screening Market is expected to grow at a significant CAGR in the upcoming
years as the scope and its applications are increasing across the globe. The
factors that propel the growth of the market include increasing demand, rapid
urbanization & industrialization, and product development &
technological innovations. In addition, some of the key factors that fuel the
market growth include implementation of strict laws mandating drug and alcohol
testing, rise in disposable income, increasing drug & alcohol consumption,
and regulatory approvals & product launches and services.
On the other hand, there are also factors that may hamper the growth of
the Drug Screening Market such as prohibition on alcohol consumption in many
Islamic countries. The market is classified on the basis of product &
services, sample type, end users, and geography. Drug Screening Industry is
categorized by product & services as Analytical Instruments, Rapid Testing
Devices, Consumables and Drug Screening Services. Analytical Instruments
segment consists of Chromatography Instruments, Immunoanalyzers and
Breathalyzers (Fuel-cell breathalyzer, Semi-conductor breathalyzer and other
breathalyzers).
Browse Full
Research Report @ https://www.millioninsights.com/industry-reports/drug-screening-market
Rapid Testing Devices segment consists of Dip cards, Drug Testing
Cassettes, Drug testing cups, Oral Fluid Testing Devices, Urine testing device,
and others. Consumables segment consists of Assay Kits, Calibrators &
Controls, Sample Collection devices, and other consumables. Among products,
Breathalyzers segment is projected to account a dominant share in the industry.
Drug Screening Market is segmented by sample type as Breath, Hair, Oral Fluid,
Urine and others. Among sample type, oral fluid segment is expected to hold a
large share in the Drug Screening Industry.
Drug Screening Market is classified by end users as Criminal Justice
Systems and Law Enforcement Agencies, Drug Treatment Centers, Drug testing
laboratories, Hospitals, Individual users, Pain Management Centers, Schools and
Colleges, Workplace, and others. The market is classified on the basis of
geography as North America, Latin America, Western Europe, Eastern Europe, Asia
Pacific, Japan and Middle East and Africa.
The North American region consists of the U.S., and Canada. Latin America
region consists of Mexico and Brazil. The Western European region consists of
Germany, Italy, France, England and Spain. The Eastern European region consists
of Poland and Russia. Asia Pacific region consists of China, India, ASEAN,
Australia & New Zealand. The Middle East and African region consists of
GCC, South Africa and North Africa.
In case of geographical region, North America is projected to hold a
major share in the Drug Screening Market. The key factors that attribute to the
growth of this region include presence of key players, technological
innovations and laws supporting drug screening. However, Asia Pacific is
expected to display high growth rates in the Drug Screening Market. Factors
such as rise in disposable income, large young population base, increasing
consumption of alcohol and illicit drugs, and rising number of drunk-driving
cases positively influence the growth of this region.
Some of the key players that fuel the growth of the Drug Screening Market
include Alere, MPD Inc., Omega Laboratories, Psychemedics, Shimadzu, Alfa
Scientific Designs, Labcorp, Siemens Healthineers, Drgerwerk, Quest
Diagnostics, Orasure, Lifeloc, Roche, Premier Biotech, Thermo Fisher
Scientific, and others. The key players are focusing on inorganic growth to
sustain themselves amidst fierce competition. As such, mergers, acquisitions,
and joint ventures are the need of the hour.
Request a Free Sample
Copy of This Report @ https://www.millioninsights.com/industry-reports/drug-screening-market/request-sample
Comments
Post a Comment